Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. VBI Vaccines Inc.
  6. Calendar
    VBIV   CA91822J1030

VBI VACCINES INC.

(VBIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on VBI VACCINES INC.
06/23/21 European association for the study of the liver meeting - abstract number: po-2575
06/23/21 European association for the study of the liver meeting - abstract number: 420
06/23/21 | 12:00pm Raymond James Human Health Innovations Conference
08/04/21 Interim 2021 Earnings Release (Projected)
Past events on VBI VACCINES INC.
06/09/21 | 12:30pm Annual General Meeting
06/04/21 American society of clinical oncology conference - abstract #: 2047
06/03/21 | 01:00pm Jefferies Healthcare Conference
05/10/21 | 08:01am Q1 2021 Earnings Release
Upcoming sector events for VBI VACCINES INC.
06/15/21 ABCELLERA BIOLOGICS INC. : Annual General Meeting
06/15/21 | 10:00am ALNYLAM PHARMACEUTICALS, INC. : Nasdaq Investor Conference
06/15/21 | 10:30am IONIS PHARMACEUTICALS, INC. : Nasdaq Investor Conference
06/15/21 | 05:30pm FATE THERAPEUTICS, INC. : Bank of America Securities Napa Biopharma Virtual Conference
More events
Past sector events for VBI VACCINES INC.
06/14/21 | 03:00pm NOVAVAX, INC. : BIO International Convention
06/13/21 | 10:00am BEIGENE, LTD. : European Hematology Association Congress - Abstract No. - S207 - Q&A Session
06/12/21 ARROWHEAD PHARMACEUTICALS, INC. : Virtual Alpha-1 National Conference
06/11/21 | 12:00pm BEIGENE, LTD. : European Hematology Association Congress
Annual publications
Annual results201620172018201920202021 (e)
Sales
M $
Released
Forecast
Spread
0,55
0,27
104%
0,87
0,95
-8,8%
3,36
3,25
3,1%
2,22
2,64
-16%
1,06
1,26
-16%

3,40
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-24,6
-22,0
-12%
-37,3
-35,3
-5,5%
-60,4
-56,3
-7,4%
-52,4
-52,0
-0,74%
-43,6
-42,8
-1,9%

-65,6
Operating profit
(EBIT)
M $
Released
Forecast
Spread


-39,4
-37,3
-5,7%
-63,6
-59,6
-6,7%
-54,8
-53,5
-2,5%
-46,2
-45,1
-2,4%

-70,8
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-23,2
-20,7
-12%
-39,0
-37,5
-3,9%
-63,6
-59,6
-6,7%
-54,8
-53,9
-1,6%
-46,2
-44,8
-3,2%

-70,8
Net income
$
Released
Forecast
Spread
-0,77
-0,73
-5,5%
-0,88
-0,88
0,00%
-0,97
-0,89
-9,4%
-0,46
-0,46
0,00%
-0,21
-0,20
-4,0%

-0,28
Announcement Date03/20/201702/26/201802/25/201903/05/202003/02/2021

Quarterly publications
Previous periodNext period
Quarterly results2020 Q12020 Q22020 Q32020 Q42021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread
0,42
0,66
-37%
0,18
0,46
-60%
0,30
0,33
-9,2%
0,16
0,41
-60%
0,30
0,49
-38%

0,55
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-9,41
-10,7
12%
-8,14
-9,97
18%
-11,9
-9,86
-20%
-14,2
-13,4
-6,4%
-15,7
-14,9
-5,3%

-15,3
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-8,36
-10,8
23%
-9,51
-10,8
12%
-13,0
-10,6
-22%
-15,4
-14,1
-8,7%
-17,6
-15,4
-15%

-16,3
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-8,36
-11,0
24%
-9,51
-9,89
3,8%
-13,0
-10,2
-27%
-15,4
-13,8
-11%
-17,6
-15,4
-15%

-16,3
Net income
$
Released
Forecast
Spread
-0,05
-0,07
23%
-0,04
-0,04
0,00%
-0,06
-0,05
-33%
-0,06
-0,06
-3,4%
-0,07
-0,06
-17%

-0,06
Announcement Date05/06/202007/31/202011/02/202003/02/202105/10/2021

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise